TY - JOUR
T1 - Incidence of polyneuropathy in Utrecht, the Netherlands
AU - Visser, Nora A.
AU - Notermans, Nicolette C.
AU - Linssen, Rosalie S N
AU - Van Den Berg, Leonard H.
AU - Vrancken, Alexander F J E
PY - 2015/1/20
Y1 - 2015/1/20
N2 - Objective: Ascertain the incidence of cryptogenic axonal polyneuropathy (CAP) and how this relates to the overall incidence of polyneuropathy. Methods: Electronic diagnostic registries of all hospital-based neurologic practices in the province of Utrecht (population 1,224,852 5 7.4% of the Dutch population) were consulted in 2010 to identify incident cases with polyneuropathy. Medical files were reviewed to specify the final diagnosis. Age-adjusted incidence rates for the Netherlands were calculated using national age-specific population figures. Results: The overall incidence of polyneuropathy was 77.0/100,000 person-years (95% confidence interval 71.1-82.8) in persons aged 18 years and older. Diabetic polyneuropathy (32%), CAP (26%), toxic polyneuropathy (14%), and immune-mediated polyneuropathy (9%) were the most frequent diagnoses. The incidence of CAP was 31.6/100,000 person-years (95%confidence interval 27.0-36.3) in persons aged 40 years and older. The incidence of polyneuropathy increased with age, as well as the proportion of patients diagnosed with CAP: 12% (40-49 years), 20% (50-59 years), 28% (60-69 years), 32% (70-79 years), and 35% (≥80 years) (χ2 test, p 5 0.005). Conclusions: The chance of establishing an etiologic diagnosis in patients presenting with a polyneuropathy decreases with age. Given the aging population, polyneuropathy in general and CAP in particular will pose a growing health care problem.
AB - Objective: Ascertain the incidence of cryptogenic axonal polyneuropathy (CAP) and how this relates to the overall incidence of polyneuropathy. Methods: Electronic diagnostic registries of all hospital-based neurologic practices in the province of Utrecht (population 1,224,852 5 7.4% of the Dutch population) were consulted in 2010 to identify incident cases with polyneuropathy. Medical files were reviewed to specify the final diagnosis. Age-adjusted incidence rates for the Netherlands were calculated using national age-specific population figures. Results: The overall incidence of polyneuropathy was 77.0/100,000 person-years (95% confidence interval 71.1-82.8) in persons aged 18 years and older. Diabetic polyneuropathy (32%), CAP (26%), toxic polyneuropathy (14%), and immune-mediated polyneuropathy (9%) were the most frequent diagnoses. The incidence of CAP was 31.6/100,000 person-years (95%confidence interval 27.0-36.3) in persons aged 40 years and older. The incidence of polyneuropathy increased with age, as well as the proportion of patients diagnosed with CAP: 12% (40-49 years), 20% (50-59 years), 28% (60-69 years), 32% (70-79 years), and 35% (≥80 years) (χ2 test, p 5 0.005). Conclusions: The chance of establishing an etiologic diagnosis in patients presenting with a polyneuropathy decreases with age. Given the aging population, polyneuropathy in general and CAP in particular will pose a growing health care problem.
UR - http://www.scopus.com/inward/record.url?scp=84925965774&partnerID=8YFLogxK
U2 - 10.1212/WNL.0000000000001160
DO - 10.1212/WNL.0000000000001160
M3 - Article
C2 - 25503982
AN - SCOPUS:84925965774
SN - 0028-3878
VL - 84
SP - 259
EP - 264
JO - Neurology
JF - Neurology
IS - 3
ER -